Upper Respiratory Disease Market Positioned to Reach $14.4 Billion

Market Drivers, Evolving Drug Classes Analyzed by Applied Data Research

[ClickPress, Thu Jul 12 2007] The prevalence of upper airway inflammatory disease is growing worldwide, and the associated morbidity is also on the rise, as patients deal with the effects of physiological and environmental factors. Inhalation forms the basis for self-administration of a number of drugs for the treatment and control of upper respiratory tract diseases. This class of conditions includes asthma, emphysema and chronic bronchitis, and represents a market of more than 300 million patients worldwide, with a projected total prescription drug value expected to reach $14.4 billion in 2010.

A significant opportunity exists to improve and expand current treatment of respiratory diseases. The inhaled respiratory market represents one of the largest categories of drug spending, with continuing growth due to increasing incidence and diagnosis of asthma and chronic obstructive pulmonary disease. Interest is growing among practitioners and their patients for inhalers that are capable of delivering two drugs that can act in concert to mitigate the effects of upper respiratory disease better than a single drug. These combination products pair drugs with different indications to maximize patient relief.

Asthma, COPD and Allergic Rhinitis: Emerging Therapeutics and Opportunities, a recently released report, analyzes prescribed drugs, combination products, market participants, and key regulatory and technology factors influencing this market and shaping growth prospects over the next four years. It is available from Applied Data Research by visiting

http://www.applieddata.org/Airway_Inflammation.htm

More information is also available at www.applieddata.org .


About Applied Data

Applied Data Research is a healthcare therapeutics consulting firm focused on medical market strategies, product commercialization, venture development, and market research. We assist medical market participants in achieving their business objectives through the creation of detailed business development strategies, product commercialization programs, and comprehensive market and technology research and analysis.

Contact:

Greg Stone
Voice: 603-595-6225
Fax: 603-804-0466
www.applieddata.org

Source: Applied Data Research

Bookmark this release: Del.icio.us - Digg - Furl - Blinklist - Reddit